Deltex Medical

Over 3000 ODM systems are used worldwide. The CardioQ–ODM has demonstrated clinical benefit by reducing postoperative complications and hospital stay duration. It has received NICE recommendation as a high-impact innovation for perioperative care. "Deltex’s robust evidence base has been established over many years... helping the company to achieve system-wide adoption of this unique medical technology." "It has sold 3000 of its main product... which measures the rate of blood flow from the heart. The company claims that it has been shown to reduce postoperative complications and reduce length of hospital stay." Devices are distributed in over 30 countries.